查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1948063

體外診斷幫浦市場依產品類型、應用、最終用戶、自動化程度、流速及材料分類，全球預測，2026-2032年

In-Vitro Diagnostics Pumps Market by Product Type, Application, End User, Automation Level, Flow Rate, Material - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年體外診斷幫浦市場價值為 2.3595 億美元，預計到 2026 年將成長至 2.4722 億美元，預計到 2032 年將達到 3.7507 億美元，複合年成長率為 6.84%。

關鍵市場統計數據
基準年 2025 2.3595億美元
預計年份：2026年 2.4722億美元
預測年份 2032 3.7507億美元
複合年成長率 (%) 6.84%

體外診斷幫浦在現代檢查室工作流程中扮演著至關重要的角色，它能夠為臨床檢測、分子診斷、照護現場和科研實驗室提供精準的流體處理。近年來，泵浦結構、材料科學和控制電子技術的進步，重新定義了人們對準確性、可重複性和生物相容性的期望。如今，從業人員需要能夠最大限度地減少檢體損失、降低污染風險並支援高度自動化工作流程的整合解決方案。

隨著診斷路徑與高通量分子方法和分散式檢查模式的融合，泵浦技術必須平衡各種不同的性能需求。本導言概述了構成當前格局的技術基礎、運作促進因素和相關人員的優先事項。它透過強調可靠性、法規遵循和互通性是製造商和最終用戶始終關注的重點，為後續分析提供了框架。本文進一步將泵浦置於更廣泛的檢查室生態系統中，指出資料完整性、通量一致性和可維護性決定了任何流體解決方案的實際價值。這有助於讀者理解下文討論的市場區隔、區域趨勢、政策影響和策略建議。

自動化、分散式檢測和分子診斷如何重塑幫浦的設計重點、連接期望和服務模式

體外診斷幫浦的市場格局正在經歷一場變革，其驅動力包括自動化、分散式檢測以及分子診斷方法的擴展。自動化正從獨立設備轉向將幫浦作為整合子系統而非獨立周邊設備設備的互聯平台。這種轉變推動了對數位化控制、通訊標準和可預測維護週期的需求，促使供應商優先考慮模組化和軟體驅動的診斷技術。

分析2025年關稅及其對供應鏈韌性、採購週期和製造地決策的策略影響

2025年的政策轉變和關稅給體外診斷幫浦的供應商和買家都帶來了複雜的營運摩擦。關稅導致關鍵零件和原料的投入成本波動，促使企業重新評估供應基地，並加速調整其進出口策略。為此，製造商加快了供應來源多元化，探索近岸外包機會，並加強了與零件供應商的談判，以維持利潤率和供應的連續性。

綜合細分分析，將產品架構、應用需求、最終用戶優先順序、自動化程度、流程控制和材料選擇連結起來

細分市場提供了一個框架，用於理解技術選擇、臨床需求和採購優先順序之間的交集，涵蓋產品類型、應用、最終用戶、自動化程度、流速和材料選擇等方面。在產品類型方面，注射式幫浦——包括公分級、多通道和單通道注射幫浦——以及蠕動式、旋轉式、雙注射器和單注射器配置，在精準度、脈動和可維護性方面各有優劣。這些差異決定了它們在臨床診斷、分子檢查室、照護現場檢驗設備和研究環境中的最佳應用場景。基於應用的區分錶明，臨床診斷中的血液學、免疫化學和微生物學需要穩健且最大限度減少污染的流體控制，而DNA定序、ELISA和PCR等分子診斷應用則需要超高精度的微量處理和嚴格的污染控制。就地檢驗需要緊湊、堅固耐用的泵，用於血液氣體分析和血糖監測，而生物技術和製藥研究實驗室則優先考慮柔軟性和化學相容性。

區域趨勢和監管環境正在影響主要全球市場的採購行為、服務模式和產品設計重點。

區域趨勢受法規結構、臨床實踐模式和供應鏈結構的影響，這為製造商、經銷商和檢查室營運商創造了獨特的機會和挑戰。在美洲，臨床診斷網路和大型醫院系統推動了對擴充性和可維護解決方案的需求，而私營部門的積極參與則促進了競爭性籌資策略和基本契約。北美檢查室網路互通性，以支援認證流程。

供應商如何透過模組化設計、服務品質、監管應對力和策略合作夥伴關係實現差異化，從而佔據技術和臨床領域的細分市場

體外診斷幫浦領域的競爭格局主要集中在技術差異化、服務能力和監管經驗方面。擁有深厚專業知識的公司正致力於開發模組化設計，以簡化檢驗和維護流程，並建立全面的文件包，從而支援在臨床和研究環境中快速部署。與試劑供應商、儀器整合商和系統整合商建立策略夥伴關係，透過展示端到端的工作流程優勢，增強解決方案的黏性並加速其應用。

為滿足不斷變化的臨床和營運需求，提供如何協調產品藍圖、供應鏈、材料策略和數位化連接方面的實用建議

產業領導者應採取務實的產品組合策略，使產品開發與新興的臨床路徑和營運需求保持一致。優先發展模組化泵平台，這些平台支援多種產品類型，並可適應各種配置，包括離心泵、蠕動泵、旋轉泵和注射泵，從而最大限度地重複利用核心控制系統，並簡化跨多個應用的檢驗。加大材料研發投入，拓展聚四氟乙烯（PTFE）、聚氯乙烯（PVC）和矽膠等材料的選擇範圍，以解決化學和生物相容性問題，同時確保不影響可製造性。

對問卷的輸入內容、驗證過程以及用於得出可操作、可復現的行業洞察的分析方法進行透明的解釋。

本研究整合了一手和二手資料，對體外診斷幫浦的市場趨勢進行了系統性且可重複的分析。一級資訊來源包括對技術領導者、採購專業人員和檢查室管理人員的訪談，以及對產品規格和服務內容的系統性檢驗。二級資訊來源包括對監管指南、檢查室規範、專利和供應商技術文獻的審查，以檢驗性能聲明並識別創新趨勢。

綜合考慮技術、營運和政策因素，提出指導策略選擇和實施重點的結論性觀點。

總而言之，體外診斷幫浦處於精密工程、臨床需求和實際操作三者交會點。泵浦控制、材料和連接方面的技術進步，使得檢測更加精準，並能更順暢地整合到自動化工作流程中。同時，去中心化和分子診斷技術的進步正在重塑幫浦的運作環境。政策和關稅趨勢的變化使得供應鏈策略變得愈發重要，迫使製造商重新思考採購、區域組裝和庫存管理方法，以維持生產的連續性和可預測性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 體外診斷幫浦市場（依產品類型分類）

  • 離心式
  • 蠕動
    • 多通道
    • 單通道
  • 旋轉
  • 注射器
    • 雙注射器
    • 單支注射器

9. 體外診斷幫浦市場依應用領域分類

  • 臨床診斷
    • 血液學
    • 免疫化學
    • 微生物學
  • 分子診斷
    • DNA定序
    • ELISA
    • PCR
  • 即時檢測
    • 血氣分析
    • 血糖監測
  • 研究所
    • 生物技術
    • 藥物研究

第10章 體外診斷幫浦市場（依最終用戶分類）

  • 學術機構
  • 診斷檢查室
  • 醫院
  • 製藥公司

第11章 體外診斷幫浦市場（依自動化程度分類）

  • 全自動
  • 手動的
  • 半自動

12. 體外診斷幫浦市場（依流速分類）

  • 高流速
  • 低流速
  • 中等流速

第13章 體外診斷幫浦市場（依材料分類）

  • PTFE
  • PVC
  • 矽酮

第14章 體外診斷幫浦市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 體外診斷幫浦市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國體外診斷幫浦市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

17. 美國體外診斷幫浦市場

第18章：中國體外診斷幫浦市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • Diener Precision Pumps Ltd.
  • F. Hoffmann-La Roche Ltd
  • Fluid-o-Tech srl
  • Grifols, SA
  • Hologic, Inc.
  • Ortho Clinical Diagnostics
  • PerkinElmer, Inc.
  • Qiagen NV
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-4F7A6D4FB714

The In-Vitro Diagnostics Pumps Market was valued at USD 235.95 million in 2025 and is projected to grow to USD 247.22 million in 2026, with a CAGR of 6.84%, reaching USD 375.07 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 235.95 million
Estimated Year [2026] USD 247.22 million
Forecast Year [2032] USD 375.07 million
CAGR (%) 6.84%

The in-vitro diagnostics pumps sector plays a foundational role in modern laboratory workflows by enabling precise fluid handling across clinical, molecular, point-of-care, and research environments. Over recent years, technical evolution in pump architectures, materials science, and control electronics has reshaped expectations for accuracy, reproducibility, and biocompatibility. Practitioners now expect integrated solutions that minimize sample loss, reduce contamination risk, and support increasingly automated workstreams.

As diagnostic pathways converge with high-throughput molecular methods and decentralized testing models, pump technologies must reconcile diverse performance requirements. This introduction outlines the technological substrates, operational drivers, and stakeholder priorities that define the current landscape. It frames the subsequent analysis by emphasizing reliability, regulatory compliance, and interoperability as persistent priorities for manufacturers and end users alike. The narrative also situates pumps within broader laboratory ecosystems, where data integrity, throughput consistency, and serviceability determine the practical value of any fluidics solution. In doing so, it prepares the reader to interpret segmentation, regional dynamics, policy impacts, and strategic recommendations presented in later sections.

How automation, decentralization of testing, and molecular diagnostics are reshaping pump design priorities, connectivity expectations, and service models

The landscape for in-vitro diagnostics pumps is undergoing transformative shifts driven by automation, decentralization of testing, and expanding molecular methodologies. Automation is moving beyond singular instrument islands toward interconnected platforms that embed pumps as integral subsystems rather than standalone peripherals. This shift elevates requirements for digital control, communication standards, and predictable maintenance cycles, prompting suppliers to prioritize modularity and software-driven diagnostics.

Simultaneously, point-of-care expansion and the rise of near-patient testing are compressing device footprints and increasing demand for compact, low-power pumps that maintain clinical-grade accuracy. Molecular diagnostics, including PCR and DNA sequencing, demand exceptional precision in low-volume transfers and contamination control, accelerating adoption of materials and designs that minimize adsorption and carryover. Materials science advances, such as biocompatible tubing and chemically resistant components, complement these trends. Finally, serviceability and total cost of ownership considerations are reshaping procurement decisions, with purchasers seeking predictable life-cycle performance and straightforward field maintenance. These converging forces are redefining product road maps and partnership strategies across the supply chain.

Analysis of 2025 tariff actions and their strategic implications for supply chain resilience, procurement cycles, and manufacturing footprint decisions

Policy shifts and tariff actions in 2025 introduced a complex layer of operational friction for suppliers and purchasers of in-vitro diagnostics pumps. Tariff measures altered input costs for key components and raw materials, generated re-evaluation of supplier footprints, and encouraged companies to reassess import-export strategies. In response, manufacturers accelerated supplier diversification, explored nearshoring opportunities, and intensified negotiations with component vendors to preserve margin and continuity of supply.

The cumulative impact extended beyond direct cost pressures. Procurement cycles elongated as buyers sought clarity on landed costs and long-term contractual terms. Some organizations pursued localized assembly or partnered with regional contract manufacturers to reduce exposure to cross-border duties. Transitionary operational measures included tighter inventory management and prioritized allocation of constrained components to critical product lines. Regulatory compliance and customs administration also required increased administrative attention, prompting firms to invest in trade expertise and to model tariff scenarios for procurement planning. Collectively, these adaptations increased organizational focus on supply chain resilience and strategic sourcing as essential capabilities for sustaining product availability and customer trust.

Comprehensive segmentation insight that connects product architectures, application demands, end-user priorities, automation levels, flow regimes, and material choices

Segmentation provides the framework to understand where engineering choices, clinical needs, and procurement priorities intersect across product type, application, end user, automation, flow rate, and material selection. By product type, centrifugal, peristaltic with multi-channel and single-channel variants, rotary, and syringe pumps with dual and single syringe configurations each address distinct accuracy, pulsation, and maintenance trade-offs; these differences determine optimal placement within clinical diagnostics, molecular labs, point-of-care devices, and research environments. Application-driven differentiation illustrates how hematology, immunochemistry, and microbiology within clinical diagnostics demand robust, contamination-minimizing fluidics, while molecular diagnostics areas such as DNA sequencing, ELISA, and PCR require ultra-precise micro-volume handling and stringent contamination controls. Point-of-care testing needs compact, robust pumps tailored for blood gas analysis and glucose monitoring, whereas research laboratories oriented to biotechnology and pharmaceutical research prioritize flexibility and chemical compatibility.

End users including academic institutes, diagnostic laboratories, hospitals, and pharmaceutical companies impose varied procurement cycles, service expectations, and validation requirements, driving manufacturers to offer tiered support and documentation. Automation level choices-fully automated, manual, and semi-automated-reflect operational priorities for throughput, operator skill, and lab layout. Flow rate considerations across high, medium, and low classes influence pump selection according to assay throughput and volume precision. Material selection among PTFE, PVC, and silicone balances chemical resistance, biocompatibility, and cost, with each material informing cleaning protocols and longevity. Together, these segmentation dimensions enable manufacturers and purchasers to align product attributes with clinical and operational objectives.

Regional dynamics and regulatory landscapes that shape procurement behavior, service models, and product design priorities across key global markets

Regional dynamics create distinct opportunities and constraints for manufacturers, distributors, and laboratory operators, shaped by regulatory frameworks, clinical practice patterns, and supply chain topology. In the Americas, clinical diagnostics networks and large hospital systems drive demand for scalable, serviceable solutions, while strong private-sector participation encourages competitive procurement strategies and value-based contracts. North American laboratory networks emphasize interoperability with laboratory information systems and compliance documentation that supports accreditation processes.

Europe, Middle East & Africa presents a heterogeneous regulatory and reimbursement landscape that rewards suppliers able to navigate diverse approval pathways and to offer flexible commercial models. In several markets, centralized public procurement and stringent quality assurance processes favor established partners with robust local support. The Asia-Pacific region combines rapid adoption of advanced molecular techniques with strong domestic manufacturing capabilities in several markets; this environment fosters price sensitivity alongside demand for innovative, compact designs suited to high-throughput and decentralized testing contexts. Across regions, manufacturers must tailor service networks, regulatory dossiers, and channel strategies to local clinical workflows and procurement behaviors to achieve durable adoption.

How suppliers differentiate through modular design, service excellence, regulatory depth, and strategic partnerships to capture technical and clinical niches

Competitive dynamics within the in-vitro diagnostics pumps space center on technological differentiation, service capability, and regulatory experience. Companies with deep domain expertise invest in modular designs that simplify validation and maintenance, and they build comprehensive documentation packages to support rapid deployment in clinical and research settings. Strategic partnerships with reagent suppliers, instrument integrators, and systems integrators enhance solution stickiness and accelerate adoption by demonstrating end-to-end workflow benefits.

Leading suppliers emphasize quality management systems, responsive field service, and spare parts logistics to minimize downtime for high-use environments such as hospital laboratories and major diagnostic networks. Others focus on specialized niches-compact pumps for point-of-care platforms or chemically resistant fluidics for pharmaceutical laboratories-to avoid direct competition and to capture premium technical segments. Channel strategies vary from direct institutional sales to distributor-led models, with many firms combining approaches to balance reach and technical support. Across the competitive set, investment in firmware security, interoperability, and validation tools increasingly defines differentiation as buyers prioritize solutions that reduce integration risk and total operational disruption.

Practical recommendations for aligning product road maps, supply chains, materials strategy, and digital connectivity to meet evolving clinical and operational needs

Industry leaders should adopt a pragmatic portfolio strategy that aligns product development with emerging clinical pathways and operational demands. Prioritize modular pump platforms that support multiple product types and can be adapted across centrifugal, peristaltic, rotary, and syringe configurations, thereby maximizing reuse of core control systems and simplifying validation across multiple applications. Invest in materials research to expand options among PTFE, PVC, and silicone in order to address chemical compatibility and biocompatibility concerns without sacrificing manufacturability.

Strengthen supply chain resilience by diversifying component sources and by evaluating regional assembly partnerships to mitigate tariff exposure and reduce lead-time variability. Enhance software and connectivity capabilities to support interoperability with laboratory information systems and to provide predictive maintenance insights that reduce downtime. Tailor commercial approaches to regional realities, recognizing that Americas, Europe, Middle East & Africa, and Asia-Pacific each demand distinct regulatory support, service models, and pricing strategies. Finally, deepen collaborations with clinical and research end users to co-develop features that address real-world workflow constraints, thereby accelerating adoption and improving clinical utility.

Transparent explanation of research inputs, validation processes, and analytical approaches used to derive practical and reproducible industry insights

This research synthesizes primary and secondary intelligence to produce a structured, reproducible analysis of the in-vitro diagnostics pumps landscape. Primary inputs include interviews with technical leaders, procurement specialists, and laboratory directors, combined with structured validation of product specifications and service offerings. Secondary inputs involve review of regulatory guidance, standards for laboratory practice, patents, and supplier technical literature to corroborate performance claims and to identify innovation trajectories.

Analytical methods emphasize cross-validation of qualitative insights with documented product capabilities and observable procurement behavior. Segmentation logic aligns product attributes with application requirements, end-user constraints, automation levels, flow regimes, and material choices. Scenario analysis examines supply chain sensitivities and policy impacts without relying on extrapolated sizing assumptions. Throughout, findings were subjected to peer review to ensure clarity, relevance, and operational applicability for stakeholders seeking to inform procurement, product development, and strategic partnerships.

Concluding perspective that synthesizes technological, operational, and policy drivers to guide strategic choices and adoption priorities

In summary, in-vitro diagnostics pumps sit at the intersection of engineering precision, clinical imperatives, and operational realities. Technological advances in pump control, materials, and connectivity are enabling higher fidelity assays and smoother integration into automated workflows, while decentralization and molecular methods are reshaping the contexts in which pumps must perform. Policy and tariff developments have heightened the importance of supply chain strategy, forcing manufacturers to reconsider sourcing, regional assembly, and inventory approaches to maintain continuity and predictability.

Looking ahead, successful organizations will combine modular hardware platforms, adaptable materials strategies, robust service networks, and secure digital interfaces to meet diverse user needs across clinical diagnostics, molecular testing, point-of-care, and research laboratories. Strategic alignment with end users and regional market dynamics will remain essential for durable adoption. The cumulative insight is that technical excellence must be paired with operational pragmatism to translate innovation into reliable, clinically accepted solutions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. In-Vitro Diagnostics Pumps Market, by Product Type

  • 8.1. Centrifugal
  • 8.2. Peristaltic
    • 8.2.1. Multi Channel
    • 8.2.2. Single Channel
  • 8.3. Rotary
  • 8.4. Syringe
    • 8.4.1. Dual Syringe
    • 8.4.2. Single Syringe

9. In-Vitro Diagnostics Pumps Market, by Application

  • 9.1. Clinical Diagnostics
    • 9.1.1. Hematology
    • 9.1.2. Immunochemistry
    • 9.1.3. Microbiology
  • 9.2. Molecular Diagnostics
    • 9.2.1. DNA Sequencing
    • 9.2.2. ELISA
    • 9.2.3. PCR
  • 9.3. Point Of Care Testing
    • 9.3.1. Blood Gas Analysis
    • 9.3.2. Glucose Monitoring
  • 9.4. Research Laboratories
    • 9.4.1. Biotechnology
    • 9.4.2. Pharmaceutical Research

10. In-Vitro Diagnostics Pumps Market, by End User

  • 10.1. Academic Institutes
  • 10.2. Diagnostic Laboratories
  • 10.3. Hospitals
  • 10.4. Pharmaceutical Companies

11. In-Vitro Diagnostics Pumps Market, by Automation Level

  • 11.1. Fully Automated
  • 11.2. Manual
  • 11.3. Semi Automated

12. In-Vitro Diagnostics Pumps Market, by Flow Rate

  • 12.1. High Flow Rate
  • 12.2. Low Flow Rate
  • 12.3. Medium Flow Rate

13. In-Vitro Diagnostics Pumps Market, by Material

  • 13.1. PTFE
  • 13.2. PVC
  • 13.3. Silicone

14. In-Vitro Diagnostics Pumps Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. In-Vitro Diagnostics Pumps Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. In-Vitro Diagnostics Pumps Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States In-Vitro Diagnostics Pumps Market

18. China In-Vitro Diagnostics Pumps Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Agilent Technologies, Inc.
  • 19.7. B. Braun Melsungen AG
  • 19.8. Becton, Dickinson and Company
  • 19.9. bioMerieux SA
  • 19.10. Bio-Rad Laboratories, Inc.
  • 19.11. Danaher Corporation
  • 19.12. DiaSorin S.p.A.
  • 19.13. Diener Precision Pumps Ltd.
  • 19.14. F. Hoffmann-La Roche Ltd
  • 19.15. Fluid-o-Tech s.r.l.
  • 19.16. Grifols, S.A.
  • 19.17. Hologic, Inc.
  • 19.18. Ortho Clinical Diagnostics
  • 19.19. PerkinElmer, Inc.
  • 19.20. Qiagen N.V.
  • 19.21. Siemens Healthineers AG
  • 19.22. Sysmex Corporation
  • 19.23. Tecan Group Ltd.
  • 19.24. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CENTRIFUGAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CENTRIFUGAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CENTRIFUGAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MULTI CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MULTI CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MULTI CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SINGLE CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SINGLE CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SINGLE CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY ROTARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY ROTARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY ROTARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY DUAL SYRINGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY DUAL SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY DUAL SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SINGLE SYRINGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SINGLE SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SINGLE SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY IMMUNOCHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY IMMUNOCHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY IMMUNOCHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY DNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY DNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY BLOOD GAS ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY BLOOD GAS ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY BLOOD GAS ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY GLUCOSE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY GLUCOSE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY GLUCOSE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SEMI AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SEMI AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY HIGH FLOW RATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY HIGH FLOW RATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY HIGH FLOW RATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY LOW FLOW RATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY LOW FLOW RATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY LOW FLOW RATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MEDIUM FLOW RATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MEDIUM FLOW RATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MEDIUM FLOW RATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PTFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PTFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PTFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 224. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 238. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 241. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 242. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 244. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 245. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 246. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 247. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 249. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 250. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 277. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 278. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 280. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 281. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 283. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 284. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 285. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 286. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 288. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 289. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 290. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 291. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 293. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 294. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 296. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 297. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 298. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 299. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 301. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 302. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 303. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED STATES IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED STATES IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES